These therapies focus on specific genetic mutations or molecular drivers, such as EGFR, ALK, ROS1, BRAF, and MET, which are commonly implicated in NSCLC. Drugs targeting these mutations ...

近日，信达生物宣布，公司自主研发的新一代ROS1酪氨酸激酶抑制剂（TKI）——达伯乐®（他雷替尼）正式获得国家药品监督管理局（NMPA）的批准上市 ...

Indian startups Pranos, Anubal Fusion, and Hylenr are advancing efforts in nuclear fusion by exploring different technological methods. These companies aim to overcome engineering challenges, ...

Even once researchers can reliably get more power out of a fusion reaction than they put in, they'll still need to overcome engineering challenges to scale up fusion energy. The experiment ...

让我们一起深入了解这个重大动态，看看它对行业和患者的影响。 Taletrectinib是一种口服的、强效的、选择性的ROS1抑制剂，专门用于治疗局部进展或转移性ROS1阳性非小细胞肺癌。它在2021年通过了中国国家药品监督管理局的审批，并由Innovent Biologics在中国市场 ...

George R. Tynan has received research funding from the US Department of Energy and the Office of Fusion Energy Sciences, and has served on numerous advisory panels to DOE and the International ...

Message reader deserializes ROS messages into plain objects. The messages are fully deserialized. Lazy messages provide on-demand access and deserialization to fields of a serialized ROS message.

I'm more of a fan of the latter, so when I was asked to review the PowerA Fusion Pro Wireless controller for Xbox Series X and PC, I wasn't sure it was the right gamepad for me. Oh, how wrong I was.

2025年刚刚伊始之际，就迎来肺癌靶向药的重磅好消息！2025年1月2日，新一代ROS1酪氨酸激酶抑制剂（TKI）己二酸他雷替尼胶囊（代号：AB-106，商品名：达伯乐）的第二项新药上市申请已获得国家药品监督管理局（NMPA）批准，用于未经ROS1-TKI治疗的局部晚期或转移 ...

To address these challenges medicinal chemists have used a macrocyclization strategy to optimize these molecules and three macrocyclic kinase inhibitors (lorlatinib [ALK/ROS1], pacritinib [Flt3/JAK2], ...

The routine biomarkers tested in NSCLC are EGFR, ALK, and ROS1. However, several additional biomarkers have been added to the ... NGS enables the identification of point mutations, insertions, ...